Your chance to comment on NICE's guidance on using hybrid closed loop systems for managing blood glucose levels in type 1 diabetes.

Your chance to comment on NICE's guidance on using hybrid closed loop systems for managing blood glucose levels in type 1 diabetes.

17 Jan 2023

Your chance to comment on NICE's guidance on using hybrid closed loop systems for managing blood glucose levels in type 1 diabetes.

Hi,

The National Institute for Health and Care Excellence (NICE) is producing guidance on using Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes in the NHS in England.

The diagnostics advisory committee has considered the evidence and the views of non-company consultees and commentators, clinical experts and patient experts and you can now comment on the Appraisal Consultation Document (ACD).  It summarises the evidence and views that have been considered, and sets out the recommendations made by the committee.

NICE is inviting you to comment and the closing date for comments is 5pm, 31 January 2023

This document should be read along with the evidence (see the committee papers).

How to comment:

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments.

You need to make your comments directly onto the online version of the consultation document.  When you go into the document you will find instructions on how to use the new commenting software.  You can also review and edit your comments before you submit them.

You can download a PDF version of the consultation document, but you can only make comments on the online version.

Here are links to the various consultation documents:

Appraisal consultation document (online commenting)

Appraisal consultation document (PDF version)

Committee papers

Public committee slides

 

About the consultation

The advisory committee is interested in receiving comments on the following:

  • Has all of the relevant evidence been taken into account?
  • Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
  • Are the recommendations sound, and a suitable basis for guidance to the NHS?

This is your chance to make your opinions and experiences heard.

As we mentioned before, the closing date for comments is 5pm, 31 January 2023

 

For more information you can click HERE.

 

Many thanks from all at Team DB : )